The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
![](https://webarchive.library.unt.edu/web/20120926132608im_/http://www.cancer.gov/images/spacer.gif)
medroxyprogesterone
A synthetic derivative of progesterone administered as an acetate salt (medroxyprogesterone acetate) with antiestrogenic activity. As a do all progestins, medroxyprogesterone binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of estrogen on estrogen-sensitive tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/web/20120926132608im_/http://www.cancer.gov/images/spacer.gif)
Synonym: | ![]() | medroxyprogesterone acetate | |
![]() | |||
US brand names: | ![]() | Curretab Depo-Provera Provera Provera Dosepak | |
![]() | |||
Abbreviation: | ![]() | MPA | |
![]() | |||
Chemical structures: | ![]() | (6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione 17alpha-hydroxy-6alpha-methylprogesterone 6alpha-methyl-17alpha-hydroxyprogesterone 6alpha-methyl-4-pregnen-17alpha-ol-3,20-dione | |
![]() |